scispace - formally typeset
H

Håkan Arheden

Researcher at Lund University

Publications -  309
Citations -  9681

Håkan Arheden is an academic researcher from Lund University. The author has contributed to research in topics: Myocardial infarction & Magnetic resonance imaging. The author has an hindex of 46, co-authored 287 publications receiving 8454 citations. Previous affiliations of Håkan Arheden include University of California, San Francisco & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Design and validation of Segment--freely available software for cardiovascular image analysis.

TL;DR: The design and validation of a cardiovascular image analysis software package (Segment) is presented and its release in a source code format is announced and made freely available for research purposes.
Journal ArticleDOI

Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats.

TL;DR: The fractional distribution volumes of gadopentetate dimeglumine and 99mTc-DTPA are similar and indicate extracellular distribution in normal myocardium and intracellular as well as extrace cellular distribution in reperfused infarction.
Journal ArticleDOI

Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy.

TL;DR: Although AVPD is less than half in patients with DCM when compared with controls and athletes, the contribution of AVPD to LV function is maintained, which can be explained by the larger short-axis area in DCM.
Journal ArticleDOI

A Pilot Study of Rapid Cooling by Cold Saline and Endovascular Cooling Before Reperfusion in Patients With ST-Elevation Myocardial Infarction

TL;DR: The protocol demonstrates the ability to reach a core body temperature of <35°C before reperfusion in all patients without delaying primary percutaneous coronary intervention and that combination hypothermia as an adjunct therapy in acute myocardial infarction may reduce infarct size at 3 days as measured by MRI.